Fortitude Family Office’s Core Laboratories CLB Stock Holding History

Fortitude Family Office’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.05K	Buy	348 +63	+22%	+$899	﹤0.01%	1182
2026 Q1	$4.79K	Hold	285	–	–	﹤0.01%	930
2025 Q4	$4.57K	Hold	285	–	–	﹤0.01%	844
2025 Q3	$3.52K	Sell	285 -92	-24%	-$1.08K	﹤0.01%	956
2025 Q2	$4.34K	Buy	377 +350	+1,296%	+$4.15K	﹤0.01%	837
2025 Q1	$405	Hold	27	–	–	﹤0.01%	1089
2024 Q4	$467	Hold	27	–	–	﹤0.01%	1221
2024 Q3	$500	Sell	27 -37	-58%	-$743	﹤0.01%	1162
2024 Q2	$1.3K	Buy	+64	New	+$1.13K	﹤0.01%	853

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fortitude Family Office's CLB Position: Q2 2026 in Review

Fortitude Family Office increased its Core Laboratories (CLB) stake by 22% in Q2 2026, buying an estimated $899 and bringing the position to 348 shares worth $4.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1182.

Fortitude Family Office first reported a position in CLB in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.79K in Q1 2026. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Fortitude Family Office held 348 shares of Core Laboratories worth $4.05K as of Q2 2026.
Fortitude Family Office bought 63 Core Laboratories shares in Q2 2026, an estimated $899.
Core Laboratories made up ﹤0.01% of Fortitude Family Office's portfolio in Q2 2026, its #1182 holding.
Fortitude Family Office first reported a position in Core Laboratories in Q2 2024 and has held it in 9 quarters since.
Fortitude Family Office's Core Laboratories position peaked at $4.79K in Q1 2026.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Fortitude Family Office's 13F filing for Q2 2026, filed 20 Jul 2026.